DENALI CAPITAL ACQUISITION CORP

Company

Semnur Pharmaceuticals, Inc.

Filed

February 10, 2023

Accession Number

0001326389-23-000577

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →